Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan.
www.marketwatch.com
#Weightloss #drugs #covered #Medicare #Medicaid #experimental #program
Related Posts

The mood of the stock market is changing fast during Iran war. How to navigate the confusion
Talk about a confusing and frustrating market. Following two days of gains fueled by optimism on an Iran war resolution,…

401(k)s may use alternative investments: Labor Department proposal
A sign is displayed at the Department of Labor Frances Perkins Building on June, 2025, in Washington. Kevin Carter |…

Iran briefly closes airspace as U.S. tensions rise, flights rerouted across region
Iranians gather while blocking a street during a protest in Kermanshah, Iran on January 8, 2026. Kamran | Afp |…

